Literature DB >> 22372668

Quantifying hepatic steatosis - more than meets the eye.

Adam P Levene1, Hiromi Kudo, Matthew J Armstrong, Mark R Thursz, Wladyslaw M Gedroyc, Quentin M Anstee, Robert D Goldin.   

Abstract

AIMS: The non-alcoholic fatty liver disease (NAFLD) activity score (NAS) is the histological tool used to assess disease severity based on steatosis, inflammation and hepatocyte ballooning. As steatosis contributes up to three of a potential eight points to NAS, it is important to quantify steatosis accurately. We sought to determine the optimum histological technique for identifying fat in tissue. METHODS AND
RESULTS: Using tissue from a mouse model of NAFLD, with validation in human liver biopsies, the percentage steatosis and fat droplet size were assessed in haematoxylin and eosin (H&E)- and Oil Red-O (ORO)-stained sections by light microscopy and digital image analysis (DIA). Results were compared to biochemical tissue triglyceride content and MRI assessment of hepatic lipid content. H&E steatosis assessment correlated poorly with tissue triglyceride concentration. However, ORO DIA exhibited much higher sensitivity and specificity for steatosis and correlated very well with triglyceride concentration in mouse and human liver (R = 0.706, P = 0.001 and R = 0.894, P =0.041, respectively). MRI-based assessment of steatosis was inaccurate.
CONCLUSIONS: ORO DIA is the most accurate method for detecting and quantifying steatosis. Although H&E-based NAS remains clinically valid in both clinical research and experimental situations, ORO DIA is a more robust technique to assess liver steatosis accurately for NAS scoring.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372668     DOI: 10.1111/j.1365-2559.2012.04193.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  28 in total

1.  Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology.

Authors:  Jurgen H Runge; Pieter J Bakker; Ingrid C Gaemers; Joanne Verheij; Theo B M Hakvoort; Roelof Ottenhoff; Aart J Nederveen; Jaap Stoker
Journal:  MAGMA       Date:  2013-11-01       Impact factor: 2.310

2.  Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.

Authors:  Savannah Tallino; Megan Duffy; Martina Ralle; María Paz Cortés; Mauricio Latorre; Jason L Burkhead
Journal:  J Nutr Biochem       Date:  2015-05-15       Impact factor: 6.048

3.  Transplantation: Assessment of liver allograft steatosis.

Authors:  James Neuberger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-30       Impact factor: 46.802

4.  Evaluation of Nonalcoholic Fatty Liver Disease in C57BL/6J Mice by Using MRI and Histopathologic Analyses.

Authors:  Jae-Eun Ryu; Woori Jo; Hyun-Ji Choi; Sungwoong Jang; Hyo-Ju Lee; Dong-Cheul Woo; Jeong Kon Kim; Kyung Won Kim; Eun Sil Yu; Woo-Chan Son
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

5.  Development of a computational high-throughput tool for the quantitative examination of dose-dependent histological features.

Authors:  Rance Nault; Dirk Colbry; Christina Brandenberger; Jack R Harkema; Timothy R Zacharewski
Journal:  Toxicol Pathol       Date:  2014-10-01       Impact factor: 1.902

6.  Alcohol-induced ketonemia is associated with lowering of blood glucose, downregulation of gluconeogenic genes, and depletion of hepatic glycogen in type 2 diabetic db/db mice.

Authors:  Mukund P Srinivasan; Noha M Shawky; Bhupendra S Kaphalia; Muthusamy Thangaraju; Lakshman Segar
Journal:  Biochem Pharmacol       Date:  2018-12-07       Impact factor: 5.858

7.  Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease.

Authors:  Annika Mehlem; Carolina E Hagberg; Lars Muhl; Ulf Eriksson; Annelie Falkevall
Journal:  Nat Protoc       Date:  2013-05-23       Impact factor: 13.491

8.  Long-term intake of 9-PAHPA or 9-OAHPA modulates favorably the basal metabolism and exerts an insulin sensitizing effect in obesogenic diet-fed mice.

Authors:  Melha Benlebna; Laurence Balas; Béatrice Bonafos; Laurence Pessemesse; Gilles Fouret; Claire Vigor; Sylvie Gaillet; Jacques Grober; Florence Bernex; Jean-François Landrier; Ondrej Kuda; Thierry Durand; Charles Coudray; François Casas; Christine Feillet-Coudray
Journal:  Eur J Nutr       Date:  2020-09-28       Impact factor: 5.614

9.  From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis.

Authors:  Rance Nault; Kelly A Fader; Anna K Kopec; Jack R Harkema; Timothy R Zacharewski; James P Luyendyk
Journal:  Toxicol Sci       Date:  2016-09-09       Impact factor: 4.849

10.  Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis, and tumorigenesis.

Authors:  Marian Kampschulte; Christiane Stöckl; Alexander C Langheinrich; Ulrike Althöhn; Rainer M Bohle; Gabriele A Krombach; Philipp Stieger; Yuri Churin; Sandra Kremer; Christian Dierkes; Timo Rath; Elke Roeb; Martin Roderfeld
Journal:  Lab Invest       Date:  2014-09-08       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.